288 related articles for article (PubMed ID: 22761383)
21. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X Complex.
Thakker S; Purushothaman P; Gupta N; Challa S; Cai Q; Verma SC
J Virol; 2015 May; 89(10):5536-56. PubMed ID: 25740990
[TBL] [Abstract][Full Text] [Related]
22. Determination of Kaposi's sarcoma-associated herpesvirus C-terminal latency-associated nuclear antigen residues mediating chromosome association and DNA binding.
Kelley-Clarke B; Ballestas ME; Srinivasan V; Barbera AJ; Komatsu T; Harris TA; Kazanjian M; Kaye KM
J Virol; 2007 Apr; 81(8):4348-56. PubMed ID: 17287261
[TBL] [Abstract][Full Text] [Related]
23. Latency-associated nuclear antigen (LANA) of Kaposi's sarcoma-associated herpesvirus interacts with origin recognition complexes at the LANA binding sequence within the terminal repeats.
Verma SC; Choudhuri T; Kaul R; Robertson ES
J Virol; 2006 Mar; 80(5):2243-56. PubMed ID: 16474132
[TBL] [Abstract][Full Text] [Related]
24. Reduction of Kaposi's Sarcoma-Associated Herpesvirus Latency Using CRISPR-Cas9 To Edit the Latency-Associated Nuclear Antigen Gene.
Tso FY; West JT; Wood C
J Virol; 2019 Apr; 93(7):. PubMed ID: 30651362
[TBL] [Abstract][Full Text] [Related]
25. Identification of host-chromosome binding sites and candidate gene targets for Kaposi's sarcoma-associated herpesvirus LANA.
Lu F; Tsai K; Chen HS; Wikramasinghe P; Davuluri RV; Showe L; Domsic J; Marmorstein R; Lieberman PM
J Virol; 2012 May; 86(10):5752-62. PubMed ID: 22419807
[TBL] [Abstract][Full Text] [Related]
26. Poly(ADP-ribose) polymerase 1 binds to Kaposi's sarcoma-associated herpesvirus (KSHV) terminal repeat sequence and modulates KSHV replication in latency.
Ohsaki E; Ueda K; Sakakibara S; Do E; Yada K; Yamanishi K
J Virol; 2004 Sep; 78(18):9936-46. PubMed ID: 15331727
[TBL] [Abstract][Full Text] [Related]
27. Functional dissection of latency-associated nuclear antigen 1 of Kaposi's sarcoma-associated herpesvirus involved in latent DNA replication and transcription of terminal repeats of the viral genome.
Lim C; Sohn H; Lee D; Gwack Y; Choe J
J Virol; 2002 Oct; 76(20):10320-31. PubMed ID: 12239308
[TBL] [Abstract][Full Text] [Related]
28. A short sequence immediately upstream of the internal repeat elements is critical for KSHV LANA mediated DNA replication and impacts episome persistence.
De León Vázquez E; Juillard F; Rosner B; Kaye KM
Virology; 2014 Jan; 448():344-55. PubMed ID: 24314665
[TBL] [Abstract][Full Text] [Related]
29. Involvement of SSRP1 in latent replication of Kaposi's sarcoma-associated herpesvirus.
Hu J; Liu E; Renne R
J Virol; 2009 Nov; 83(21):11051-63. PubMed ID: 19710137
[TBL] [Abstract][Full Text] [Related]
30. Protein interactions targeting the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus to cell chromosomes.
Krithivas A; Fujimuro M; Weidner M; Young DB; Hayward SD
J Virol; 2002 Nov; 76(22):11596-604. PubMed ID: 12388720
[TBL] [Abstract][Full Text] [Related]
31. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen modulates K1 expression through its cis-acting elements within the terminal repeats.
Verma SC; Lan K; Choudhuri T; Robertson ES
J Virol; 2006 Apr; 80(7):3445-58. PubMed ID: 16537612
[TBL] [Abstract][Full Text] [Related]
32. Accumulation of heterochromatin components on the terminal repeat sequence of Kaposi's sarcoma-associated herpesvirus mediated by the latency-associated nuclear antigen.
Sakakibara S; Ueda K; Nishimura K; Do E; Ohsaki E; Okuno T; Yamanishi K
J Virol; 2004 Jul; 78(14):7299-310. PubMed ID: 15220403
[TBL] [Abstract][Full Text] [Related]
33. KSHV LANA--the master regulator of KSHV latency.
Uppal T; Banerjee S; Sun Z; Verma SC; Robertson ES
Viruses; 2014 Dec; 6(12):4961-98. PubMed ID: 25514370
[TBL] [Abstract][Full Text] [Related]
34. A novel KRAB-Zinc finger protein interacts with latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus and activates transcription via terminal repeat sequences.
Watanabe A; Higuchi M; Fukushi M; Ohsawa T; Takahashi M; Oie M; Fujii M
Virus Genes; 2007 Apr; 34(2):127-36. PubMed ID: 17143723
[TBL] [Abstract][Full Text] [Related]
35. NDRG1 facilitates the replication and persistence of Kaposi's sarcoma-associated herpesvirus by interacting with the DNA polymerase clamp PCNA.
Zhang F; Liang D; Lin X; Zou Z; Sun R; Wang X; Liang X; Kaye KM; Lan K
PLoS Pathog; 2019 Feb; 15(2):e1007628. PubMed ID: 30811506
[TBL] [Abstract][Full Text] [Related]
36. The ubiquitin-specific protease USP7 modulates the replication of Kaposi's sarcoma-associated herpesvirus latent episomal DNA.
Jäger W; Santag S; Weidner-Glunde M; Gellermann E; Kati S; Pietrek M; Viejo-Borbolla A; Schulz TF
J Virol; 2012 Jun; 86(12):6745-57. PubMed ID: 22514345
[TBL] [Abstract][Full Text] [Related]
37. The Kaposi Sarcoma Herpesvirus Latency-associated Nuclear Antigen DNA Binding Domain Dorsal Positive Electrostatic Patch Facilitates DNA Replication and Episome Persistence.
Li S; Tan M; Juillard F; Ponnusamy R; Correia B; Simas JP; Carrondo MA; McVey CE; Kaye KM
J Biol Chem; 2015 Nov; 290(47):28084-28096. PubMed ID: 26420481
[TBL] [Abstract][Full Text] [Related]
38. The latency-associated nuclear antigen interacts with MeCP2 and nucleosomes through separate domains.
Matsumura S; Persson LM; Wong L; Wilson AC
J Virol; 2010 Mar; 84(5):2318-30. PubMed ID: 20032179
[TBL] [Abstract][Full Text] [Related]
39. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts preferentially with the terminal repeats of the genome in vivo and this complex is sufficient for episomal DNA replication.
Fejér G; Medveczky MM; Horvath E; Lane B; Chang Y; Medveczky PG
J Gen Virol; 2003 Jun; 84(Pt 6):1451-1462. PubMed ID: 12771414
[TBL] [Abstract][Full Text] [Related]
40. Kaposi's Sarcoma-Associated Herpesvirus LANA Modulates the Stability of the E3 Ubiquitin Ligase RLIM.
Tadmor H; Greenway M; Ahuja A; Orgil O; Liao G; Ambinder RF; Hayward SD; Shamay M
J Virol; 2020 Feb; 94(5):. PubMed ID: 31801865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]